Meta Transition

At CZI, we work in areas where we think we can have an outsized impact through technology development, interdisciplinary research collaborations, and partnerships.

With Meta, our goal was to give researchers, patient communities, science societies, and research organizations more ways to discover the research they need. We did this by mapping biomedical knowledge to help researchers learn a new area or keep up-to-date in a field through precise and flexible feed design, personalized ranking, and surfacing the broadest array of research outputs.

We recognize that Meta is one of many discovery tools available to the research community operating in a complex ecosystem. Since its transition from beta to a public release in fall 2019, more organizations and communities have entered the research discovery space, and they are already exploring and experimenting with new technologies to enhance discovery and keep current with research.

Five years into our journey at CZI Science, we have learned more about what approaches we should be taking to have an outsized impact in the field. We believe that our CZI Science Technology team is best positioned to meet the needs of the research community by focusing its work across more specifically defined domains, including infectious disease, imaging, and single-cell biology. By focusing our CZI Science Technology team in these domain areas, we will bring more immediate value to the field and have greater opportunity for outsized impact, ultimately bringing us closer to our shared mission to support the science and technology that will make it possible to cure, prevent, or manage all disease by the end of the century.

As part of this transition, the technology powering Meta will remain available to the community; we will support access to the Meta application and associated services, including the Digests and API, through March 31, 2022. We will also support our users’ transition to alternative open services.

We are grateful to everyone who contributed to this project over the years and look forward to continuing to work in partnership with the scientific community to accelerate science.

Supporting the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of the century.